| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.1 | 0.7 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |